GHK-CU 50mg

Description

GHK-CU 50mg — copper-binding tripeptide, research catalogue listing

GHK-Cu is a copper-binding tripeptide studied in extracellular matrix and wound-healing research. Because the copper complex itself drives much of the observed behaviour, the material specification matters alongside the peptide sequence. This listing covers the GHK-CU 50mg presentation supplied by Polaris Peptides for laboratory and investigative work only.

What the GHK-CU 50mg listing states

Supplied as lyophilised material with a stated purity greater than 99% by HPLC-MS, vacuum-sealed and protected from light. The copper complex is sensitive to light exposure, which is why the vial is packaged to limit it. Strength is stated in milligrams on the listing itself rather than inferred from the container, and each strength in the catalogue is priced as a separate item so a protocol can be costed without unit conversion by hand.

Before ordering, check the strength against your study protocol. If you need a different strength, review its separate product page.

Choosing the GHK-CU 50mg presentation

The larger presentation is intended for extended study schedules or for work that repeats across several batches. Because material degrades with repeated handling, planning the full schedule before opening the vial matters more at this quantity.

Handling and storage for GHK-CU 50mg

Hold the sealed vial dry at −20 °C before use. Once reconstituted, keep the material at 2–8 °C and complete planned work within a defined window rather than holding solutions indefinitely. Protect from light, and avoid repeated freeze–thaw cycles, which degrade peptide material faster than steady cold storage.

On arrival, inspect the vial before storage. Record the batch reference. You may need it when requesting documentation.

Documentation and batch reference

You can ask whether a certificate of analysis is available before ordering. Check that any certificate matches the batch you receive. A certificate for an earlier batch does not cover a later one.

Research context for GHK-CU

Research on this tripeptide covers collagen synthesis, matrix remodelling and cellular migration endpoints. Comparative studies often vary the copper concentration rather than the peptide, so both aspects of the methods are worth checking. Independent literature is searchable through published studies on PubMed. Reading primary studies before committing to a protocol is standard practice in this area.

Research-only scope

GHK-CU 50mg is supplied strictly for research and investigative purposes. It is not for human or veterinary use and is not intended for clinical, therapeutic or diagnostic application. Buyers are responsible for holding the appropriate facilities, training and safety procedures for the work they intend to carry out.